Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 6/20 | 0.59 |
| ▸ | CYP2A6 | P11509 | 5/20 | 0.59 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.48 |
| ▸ | CCR1 | P32246 | 1/20 | 0.43 |
| ▸ | CCR5 | P51681 | 1/20 | 0.43 |
| ▸ | CCR8 | P51685 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | TSHR | P16473 | 3/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.39 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.39 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 2/20 | 0.38 |
| ▸ | NCK1 | P16333 | 1/20 | 0.37 |
| ▸ | BACE1 | P56817 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 1/20 | 0.37 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1760714 | 0.88 | CYP1A2 (0.61) | CYP1A2CYP2A6TDP1ALDH1A1HPGD | |
| SCHEMBL29390075 | 0.88 | CYP1A2 (0.61) | CYP1A2CYP2A6TDP1ALDH1A1HPGD | |
| SCHEMBL5745394 | 0.86 | ALDH1A1 (0.55) | CYP1A2CYP2A6TDP1CCR1CCR5 | |
| SCHEMBL15590697 | 0.86 | CYP2A6 (0.46) | CYP1A2CYP2A6TDP1CCR1CCR5 | |
| SCHEMBL23181252 | 0.86 | CYP1A2 (0.46) | CYP1A2CYP2A6TDP1CCR1CCR5 | |
| SCHEMBL4884877 | 0.84 | CYP1A2 (0.50) | CYP1A2CYP2A6TDP1CCR1CCR5 | |
| SCHEMBL5751101 | 0.84 | CYP2A6 (0.43) | CYP1A2CYP2A6TDP1CCR1CCR5 | |
| SCHEMBL9701854 | 0.80 | ALDH1A1 (0.68) | CYP1A2CYP2A6TDP1CCR1CCR5 | |
| SCHEMBL2820498 | 0.80 | CYP1A2 (0.43) | CYP1A2CYP2A6TDP1CCR1CCR5 | |
| SCHEMBL20345297 | 0.78 | ALDH1A1 (0.43) | CYP1A2CYP2A6TDP1CCR1CCR5 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | BRILLIANT LIGHT POWER, INC. (US) | 2026-02-03 | — | — | US | disclosed |
| US-12227625-B2 | Composite materials comprising mechanical ligands | NANOCORE APS (DK) | 2025-02-18 | — | — | US | disclosed |
| CN-107446606-B | Process and device for producing modified asphalt, aliphatic hydrocarbon and aromatic hydrocarbon from coal tar | 西北大学 | 2024-01-23 | — | — | CN | disclosed |
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | JSI SILICONE CO. (KR) | 2023-06-27 | — | — | US | disclosed |
| US-20230045778-A9 | HETEROGENEOUS HYDROGEN-CATALYST SOLID FUEL REACTION MIXTURE AND REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2023-02-09 | — | — | US | disclosed |
| EP-4119598-A1 | NANOCOMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS | Nanocore ApS (DK) | 2023-01-18 | — | — | EP | disclosed |
| EP-3737711-B1 | COMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS | NANOCORE APS (DK) | 2022-04-06 | — | — | EP | disclosed |
| US-20210188739-A1 | METHOD FOR PRODUCING ARENE COMPOUNDS AND ARENE COMPOUNDS PRODUCED BY THE SAME | JSI SILICONE CO. (KR) | 2021-06-24 | — | — | US | disclosed |
| EP-3737711-A1 | COMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS | Nanocore Aps (DK) | 2020-11-18 | — | — | EP | disclosed |
| US-20200354220-A1 | COMPOSITE MATERIALS COMPRISING MECHANICAL LIGANDS | NANOCORE APS (DK) | 2020-11-12 | — | — | US | disclosed |
| US-20200299130-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. (US) | 2020-09-24 | — | — | US | disclosed |
| EP-3386989-B1 | NAPHTHOINDACENODITHIOPHENES AND POLYMERS | BASF SE (DE) | 2019-10-23 | — | — | EP | disclosed |
| CN-102164849-B | Heterogeneous hydrogen-catalyst reactor | 辉光能源公司 | 2016-11-09 | — | — | CN | disclosed |
| US-20110114075-A1 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BRILLIANT LIGHT POWER, INC. | 2011-05-19 | — | — | US | disclosed |
| EP-2318307-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | Blacklight Power, Inc. (US) | 2011-05-11 | — | — | EP | disclosed |
| WO-2010127548-A1 | LIQUID FLUORESCENT COMPOSITION AND LIGHT EMITTING DEVICE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (CN) | 2010-11-11 | — | — | WO | disclosed |
| WO-2010014684-A2 | HETEROGENEOUS HYDROGEN-CATALYST REACTOR | BLACKLIGHT POWER, INC. (US) | 2010-02-04 | — | — | WO | disclosed |
| US-6432294-B1 | ELECTROCHEMICAL OXIDATION OF DISULFIDES IN ARENE SOLUTIONS FOR SYNTHESIS OF ORGANOTHIATED PRODUCT | THE UNIVERSITY OF ARIZONA | 2002-08-13 | — | — | US | disclosed |
| US-6207838-B1 | ELECTROLYSIS IN LIQUID SULFUR DIOXIDE | THE UNIVERSITY OF ARIZONA | 2001-03-27 | — | — | US | disclosed |
| EP-1048752-A2 | Electrochemically generated organothiating reagents and their use | ALBEMARLE CORPORATION (US) | 2000-11-02 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210188739-A1 | METHOD FOR PRODUCING ARENE COMPOUNDS AND ARENE COMPOUNDS PRODUCED BY THE SAME | PFAS, FRK, AGPAT2 | CYP1A2 303/4885CYP2A6 121/4885TDP1 3998/4885 |
| US-12540073-B2 | Heterogeneous hydrogen-catalyst solid fuel reaction mixture and reactor | SCO2, SOD1, HAO2 | CYP1A2 1592/4885CYP2A6 4027/4885TDP1 4237/4885 |
| US-11685702-B2 | Method for producing arene compounds and arene compounds produced by the same | PFAS, FRK, AGPAT2 | CYP1A2 303/4885CYP2A6 121/4885TDP1 3998/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.